We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

201 hedge funds and large institutions have $2.4B invested in NEVRO CORP. in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 89 increasing their positions, 46 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 46

22% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 41

4% more funds holding

Funds holding: 193201 (+8)

14% less capital invested

Capital invested by funds: $2.8B → $2.4B (-$397M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

25% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $19.6M

Holders
201
Holders Change
+8
Holders Change %
+4.15%
% of All Funds
5.01%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
50
Increased
89
Reduced
46
Closed
41
Calls
$14.7M
Puts
$19.6M
Net Calls
-$4.91M
Net Calls Change
-$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
Mirae Asset Global Investments
101
Mirae Asset Global Investments
South Korea
$1.5M +$1.61M +20,101 New
SPPAM
102
Summit Partners Public Asset Management
Massachusetts
$1.49M -$6.01M -75,000 -79%
HCMT
103
Highland Capital Management (Texas)
Texas
$1.49M +$1.6M +20,000 New
MLICM
104
Metropolitan Life Insurance Company (MetLife)
New York
$1.41M +$172K +2,145 +13%
N
105
Nuveen
North Carolina
$1.32M +$68.3K +853 +5%
AIG
106
American International Group
New York
$1.28M +$211K +2,637 +18%
OC
107
Oppenheimer & Co
New York
$1.24M +$1.33M +16,623 New
State Board of Administration of Florida Retirement System
108
State Board of Administration of Florida Retirement System
Florida
$1.11M +$325K +4,051 +37%
T. Rowe Price Associates
109
T. Rowe Price Associates
Maryland
$1.08M +$250K +3,121 +27%
AQR Capital Management
110
AQR Capital Management
Connecticut
$1.05M +$219K +2,731 +24%
RA
111
Royce & Associates
New York
$1.04M +$1.12M +14,000 New
Bank of Montreal
112
Bank of Montreal
Ontario, Canada
$982K +$283K +3,534 +37%
UBS AM
113
UBS AM
Illinois
$962K +$123K +1,533 +13%
VOYA Investment Management
114
VOYA Investment Management
Georgia
$952K -$36.8M -459,230 -97%
CS
115
Credit Suisse
Switzerland
$924K -$5.24M -65,468 -84%
MWNA
116
Marshall Wace North America
New York
$891K +$557K +6,958 +137%
TAM
117
TFG Asset Management
Cayman Islands
$849K
Barclays
118
Barclays
United Kingdom
$843K -$342K -4,263 -27%
Allianz Asset Management
119
Allianz Asset Management
Germany
$832K -$68.7K -858 -7%
Legal & General Group
120
Legal & General Group
United Kingdom
$806K +$212K +2,650 +33%
DIA
121
Denver Investment Advisors
Colorado
$756K +$35.6K +445 +5%
Russell Investments Group
122
Russell Investments Group
United Kingdom
$744K -$5.08M -63,398 -86%
DekaBank Deutsche Girozentrale
123
DekaBank Deutsche Girozentrale
Germany
$725K +$801K +10,000 New
BG
124
Bellevue Group
Switzerland
$722K +$80.1K +1,000 +11%
FMT
125
First Mercantile Trust
Tennessee
$715K -$356K -4,449 -32%

NVRO Hedge Fund Activity: Q2 2017 in Review

201 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2017, worth a combined $2.4B — down 14% from $2.8B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new NVRO positions and 41 closed out — a net gain of 9 holders — while 89 added to existing stakes and 46 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $114M. The largest seller was Fidelity Investments, cutting an estimated $78.3M.

  • 201 institutional investors held NEVRO CORP. (NVRO) as of Q2 2017, up from 193 in Q1 2017.
  • Funds reported $2.4B of NEVRO CORP. stock for Q2 2017, down 14% quarter-over-quarter.
  • 50 funds opened new NEVRO CORP. positions in Q2 2017 and 41 closed out, a net change of +9 holders.
  • The largest NEVRO CORP. buyer in Q2 2017 was Janus Henderson Group, an estimated $114M added.
  • The largest NEVRO CORP. seller in Q2 2017 was Fidelity Investments, an estimated $78.3M sold.

Based on aggregated 13F filings for Q2 2017.